BioLineRx (BLRX) Posts Q3 Loss of 1c/ADS

November 10, 2014 7:45 AM EST

BioLineRx (NASDAQ: BLRX) reported Q3 EPS of ($0.01), $0.16 better than the analyst estimate of ($0.17).

For earnings history and earnings-related data on BioLineRx (BLRX) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings